Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
This study has been terminated.
( Researchers terminated study due to limited enrollment. )
Study NCT00539513 Information provided by Yale University
First Received on October 2, 2007. Last Updated on March 25, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obsessive-Compulsive Disorder
More general conditions related to this trial
Anxiety Disorders
Mental Disorders
Interventions listed in this trial
N-Acetylcysteine
placebo
Additional drug interventions recognized in this trial
Acetylcysteine
N-monoacetylcystine
Serotonin Uptake Inhibitors
More general drug interventions related to this trial
Anti-Infective Agents
Antidotes
Antioxidants
Antiviral Agents
Expectorants
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Serotonin Agents
Therapeutic Uses
Sponsors listed in this trial
Yale University
Back to top of Main Content